Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Procysbi in cysteamine-naïve patients with cystinosis
NCT01744782Phase 3Completed
- Sponsor
- Amgen
- Start
- Dec 2012
- Primary completion
- Dec 2016
- Countries
- 2
01
Overview
A Phase 3 trial of cysteamine in cystinosis, sponsored by Amgen. Started Dec 2012; status: completed.
02
Drugs
cysteamine
03
Conditions
cystinosis
Beyond the preview
Go deeper on NCT01744782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01744782.